A New Viewpoint on the Lancet Commission on Women, Power, and Cancer
The Lancet Group shared a post on LinkedIn:
“Cancer has a disproportionate impact on the lives and livelihoods of women.
In 2023, the Lancet Commission on Women, Power, and Cancer provided 10 priority actions for achieving equitable cancer prevention, treatment, and care—including:
- Ensuring data on sex and gender is collected in cancer health statistics.
- Researching, and acting on emerging cancer risks that disproportionately affect girls and women.
- Ensuring equitable access to cancer research resources, leadership, and funding opportunities for women.
In a new Viewpoint, Commissioners provide a framework to guide implementation of these recommendations.
Find out more.
Figure from the 2023 Lancet Commission: An intersectional feminist framework for cancer.”
A proposed framework for monitoring and evaluating progress at the intersection of women, power, and cancer.
Authors: Elise M Garton, Gavin Allman, Hyo Sook Bae, Kalina Duncan, Ibithal Fadhil, Nazik Hammad, Shirin Heidari, Erica Liebermann, Meritxell Mallafré-Larrosa, Jennifer Moodley, Rachel Nugent, Isabelle Soerjomataram, Carolyn D Taylor, Karla Unger-Saldaña, Verna Vanderpuye, Ophira Ginsburg.
You can read the full article on Journal of The Lancet.
More posts featuring The Lancet Group.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023